Navigation Links
Immucor Announces New Vice President, Operations
Date:1/19/2009

NORCROSS, Ga., Jan. 19 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that Michael Pred has joined the Company as Vice President, Operations, responsible for overseeing all U.S. manufacturing operations.

Mr. Pred has more than 15 years pharmaceutical manufacturing experience with both Pfizer and Merck & Co. Most recently, he led all manufacturing in a multi-plant operation for vaccine production for Pfizer Animal Health. Prior to joining Pfizer, Mr. Pred held various manufacturing leadership roles at Merck. He spent seven years in the U.S. Navy, as a nuclear-trained submarine officer. Mr. Pred holds a B.S. in chemical engineering from the University of Wisconsin.

"With his strong working knowledge of manufacturing best practices and his proven commitment to excellence, Mike will help Immucor maintain our strong commitment to product quality and quality compliance while enhancing manufacturing efficiency," stated Dr. Gioacchino De Chirico.

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com .


'/>"/>
SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
2. Immucor Closes BioArray Acquisition
3. Immucor Schedules Fiscal 2009 Guidance Call
4. Immucor Responding to FDA Warning Letter
5. Immucor Announces Record Fiscal Third Quarter Results
6. Immucor Schedules Third Quarter Earnings Release and Conference Call
7. Immucor, Inc. Adds Director to Board
8. Immucor Announces Update to Second Quarter Conference Call Number
9. Immucor, Inc. Appoints New Chief Financial Officer
10. Immucor Announces Record Fiscal First Quarter Revenues
11. Immucor Schedules First Quarter Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
Breaking Medicine Technology: